{"id":"https://openalex.org/W4394200216","doi":"https://doi.org/10.6084/m9.figshare.23462505","title":"The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials","display_name":"The efficacy and safety of Capivasertib (AZD5363) in the treatment of patients with solid tumor: a systematic review and meta-analysis of randomized clinical trials","publication_year":2023,"publication_date":"2023-01-01","ids":{"openalex":"https://openalex.org/W4394200216","doi":"https://doi.org/10.6084/m9.figshare.23462505"},"language":"en","primary_location":{"id":"pmh:oai:figshare.com:article/23462505","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/The_efficacy_and_safety_of_Capivasertib_AZD5363_in_the_treatment_of_patients_with_solid_tumor_a_systematic_review_and_meta-analysis_of_randomized_clinical_trials/23462505","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://figshare.com/articles/dataset/The_efficacy_and_safety_of_Capivasertib_AZD5363_in_the_treatment_of_patients_with_solid_tumor_a_systematic_review_and_meta-analysis_of_randomized_clinical_trials/23462505","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5068391438","display_name":"Aws Khalid Abushanab","orcid":"https://orcid.org/0000-0003-0874-666X","observed_orcids":["https://orcid.org/0000-0003-0874-666X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Abushanab, Aws Khalid","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051212686","display_name":"Mahmoud Taysir Mousa","orcid":"https://orcid.org/0000-0003-3935-6410","observed_orcids":["https://orcid.org/0000-0003-3935-6410"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mousa, Mahmoud Taysir","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101851150","display_name":"Mus\u2019ab Theeb Mustafa","orcid":"https://orcid.org/0000-0002-6624-7554","observed_orcids":["https://orcid.org/0000-0002-6624-7554"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mustafa, Mus\u2019ab Theeb","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5016008951","display_name":"Rana Ahmed Qawaqzeh","orcid":"https://orcid.org/0000-0002-3566-2683","observed_orcids":["https://orcid.org/0000-0002-3566-2683"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Qawaqzeh, Rana Ahmed","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.00972933,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.9053000211715698,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12829","display_name":"Advanced Breast Cancer Therapies","score":0.08070000261068344,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11914","display_name":"PARP inhibition in cancer therapy","score":0.0015999999595806003,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/capivasertib","display_name":"capivasertib","score":0.9760000109672546},{"id":"https://openalex.org/keywords/azd5363","display_name":"AZD5363","score":0.9829999804496765},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.847000002861023},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9089999794960022},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9959999918937683},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.8730000257492065},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.7360000014305115},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/hormone-therapy","display_name":"hormone therapy","score":0.8389999866485596},{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.4560000002384186}],"concepts":[{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.5911127924919128},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5671517848968506},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4856354296207428},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4663870334625244},{"id":"https://openalex.org/C19527891","wikidata":"https://www.wikidata.org/wiki/Q1120908","display_name":"Medical physics","level":1,"score":0.39496782422065735},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.34585249423980713},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3062356114387512}],"mesh":[],"locations_count":4,"locations":[{"id":"pmh:oai:figshare.com:article/23462505","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/The_efficacy_and_safety_of_Capivasertib_AZD5363_in_the_treatment_of_patients_with_solid_tumor_a_systematic_review_and_meta-analysis_of_randomized_clinical_trials/23462505","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.23462505","doi":"https://doi.org/10.6084/m9.figshare.23462505","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23462505","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.23462505.v1","doi":"https://doi.org/10.6084/m9.figshare.23462505.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23462505.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"},{"id":"doi:10.6084/m9.figshare.23462505.v2","doi":"https://doi.org/10.6084/m9.figshare.23462505.v2","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.23462505.v2","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Dataset"}],"best_oa_location":{"id":"pmh:oai:figshare.com:article/23462505","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/dataset/The_efficacy_and_safety_of_Capivasertib_AZD5363_in_the_treatment_of_patients_with_solid_tumor_a_systematic_review_and_meta-analysis_of_randomized_clinical_trials/23462505","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Dataset"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W7221525210","https://openalex.org/W4415145011","https://openalex.org/W7091507524","https://openalex.org/W4248369563","https://openalex.org/W2921352499","https://openalex.org/W4410802733","https://openalex.org/W4390232274","https://openalex.org/W4404042638","https://openalex.org/W4393867322","https://openalex.org/W7129198417"],"abstract_inverted_index":{"To":[0],"evaluate":[1],"the":[2,42,63,87,111,176],"clinical":[3],"efficacy":[4,170],"and":[5,25,37,136,171],"safety":[6,173],"of":[7,47,69,86,142,178],"Capivasertib":[8,59,107,135,143,159],"on":[9,28],"patients":[10,30],"with":[11,31,66,90,114,180],"solid":[12,32,181],"tumors.":[13],"Data":[14],"from":[15,50],"four":[16,51,128],"RCTs":[17,52],"were":[18,41,53,130,138],"pooled":[19],"to":[20,145],"create":[21],"a":[22],"systematic":[23],"review":[24],"meta-analysis":[26],"focusing":[27],"Capivasertib-treated":[29],"tumor.":[33,182],"Progression-free":[34],"survival":[35],"(PFS)":[36],"adverse":[38],"events":[39],"(AE)":[40],"primary":[43],"outcomes.":[44],"A":[45],"total":[46],"540":[48],"individuals":[49,179],"included.":[54],"The":[55,102],"analysis":[56,103],"showed":[57,105],"that":[58,106],"improved":[60,108],"PFS":[61,85],"for":[62,110],"ITT":[64,112],"population":[65,113],"an":[67,91,115],"HR":[68,92,116],"0.75":[70],"(95%":[71,95,119],"CI":[72,96,120,153],"=":[73,76,93,97,100,117,121,124,150,154,157],"0.62\u20130.90,":[74],"p":[75,99,123,156],"0.002),":[77],"whereas":[78],"it":[79],"did":[80],"not":[81],"show":[82],"improvement":[83],"in":[84,140,175],"PI3K/AKT/PTEN-altered":[88],"group":[89],"0.61":[94,118],"0.32\u20131.16,":[98],"0.13).":[101],"also":[104],"OS":[109],"0.47\u20130.78,":[122],"0.0001).":[125],"For":[126],"safety,":[127],"studies":[129],"included;":[131],"statistical":[132],"differences":[133],"between":[134],"placebo":[137],"found":[139],"discontinuation":[141],"due":[144],"toxicity":[146],"or":[147,162],"AE":[148],"(RR":[149],"2.37,":[151],"95%":[152],"1.37\u20134.10,":[155],"0.002).":[158],"plus":[160],"chemotherapy":[161],"hormonal":[163],"therapy":[164],"combination":[165],"has":[166],"shown":[167],"promising":[168,172],"antitumor":[169],"profile":[174],"treatment":[177]},"counts_by_year":[],"updated_date":"2026-10-08T09:06:37.294493","created_date":"2024-04-08T00:00:00"}